- ►diabetesjournals.org M Fernandez, C Triplitt, E Wajcberg, AA … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—The decreases in A1C (∼9.0–7.0%) and fasting plasma glucose (∼190–128
mg/dl) were equal in all groups. In the PIO group, glucose disposal increased from 3.1 to 4.7
mg · kg −1 · min −1 , and there was a greater decrease in plasma triglycerides (∼148 vs. ... Cited by 12 - Related articles - BL Direct - All 6 versions
K Berneis, M Rizzo, C Stettler, B Chappuis … - Expert Opin. …, 2008 - informahealthcare.com Objective: To assess the effects of pioglitazone and rosiglitazone on fasting and postprandial
low-density lipoprotein (LDL) size and subclasses in patients with Type 2 diabetes. Research
design and methods: Nine Type 2 diabetic patients (age 61 ± 10 years, body mass index ... Cited by 10 - Related articles - BL Direct - All 6 versions
MD Marianella Fernandez, CT PharmD, E Wajcberg, … - Am Diabetes Assoc Correspondence: Eugenio Cersosimo MD, Ph.D. Mail Code 7886 7703 Floyd Curl Drive San
Antonio, Texas, 78229-3900 E-mail: Eugenio.Cersosimo@uhs-sa.com ... Received for publication
11 April 2007 and accepted in revised form 27 September 2007. Related articles - All 2 versions
- ►endojournals.org E Wajcberg, A Sriwijitkamol, N Musi, RA … - Journal of Clinical …, 2007 - Endocrine Soc Context: Vascular dysfunction and insulin resistance precede atherosclerosis in type 2 diabetes
(T2DM). Better knowledge of the interaction between these is of considerable clinical
interest. ... Objective: The objective of this study was to examine the association between ... Cited by 6 - Related articles - BL Direct - All 4 versions
P Berhanu, A Perez, S Yu - Diabetes, Obesity & Metabolism, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 6 - Related articles - All 3 versions
[CITATION] Biomarkers of vascular disease linking inflammation to endothelial activation. Part …
- ►dvdres.com [PDF] G Perriello, S Pampanelli, P Brunetti, CD … - Diabetes & Vascular …, 2007 - dvr.sagepub.com Abstract T his study compared the long-term effects of pioglita- zone and gliclazide on the production
of coagulation factors in patients with type 2 diabetes. Patients (n=283) with glycosylated haemoglobin
> 7.5% were ran- domised to receive either pioglitazone (30–45 mg/day) or gliclazide ... Cited by 2 - Related articles - BL Direct - All 9 versions
W Leonhardt, A Pfützner, J Müller, J Pietzsch, T Forst, E … - Atherosclerosis, 2008 - Elsevier We analyzed the efficacy and possible synergistic actions of pioglitazone and simvastatin monotherapy
versus their combination on LDL subfractions from a subpopulation from the PIOSTAT
three-arm randomized controlled trial. PPARγ agonists, such as pioglitazone, improve ... Cited by 4 - Related articles - All 31 versions
